Table 1 Comparison of patient characteristics according to MVI
From: Clinical and DCE-CT signs in predicting microvascular invasion in cHCC-ICC
Characteristics | Total | MVI N(%) | Statistic | P value | |
|---|---|---|---|---|---|
mvi = 0 | mvi = 1 | ||||
Total | 119 | 68(57.14) | 51(42.86) | ||
Age | 52.41 ± 10.36 | 54.35 ± 9.10 | 49.80 ± 11.44 | 0.82 | 0.41 |
sex | 0.33 | 0.57 | |||
male | 105 | 59(56.19) | 46(43.81) | . | . |
female | 14 | 9(64.29) | 5(35.71) | . | . |
AFP | . | 2.88 | 0.09 | ||
0 | 55 | 36(65.45) | 19(34.55) | . | . |
1 | 64 | 32(50.00) | 32(50.00) | . | . |
CEA | . | 5.29 | 0.02 | ||
0 | 105 | 49(46.67) | 56(53.33) | . | . |
1 | 14 | 2(14.29) | 12(85.71) | . | . |
CA-199 | . | 2.64 | 0.10 | ||
0 | 79 | 41(51.90) | 38(48.10) | . | . |
1 | 40 | 27(67.50) | 13(32.50) | . | . |
Hepatitis B | . | 1.11 | 0.29 | ||
0 | 34 | 22(64.71) | 12(35.29) | . | . |
1 | 85 | 46(54.12) | 39(45.88) | . | . |
Cirrhosis | . | 0.64 | 0.43 | ||
0 | 54 | 33(61.11) | 21(38.89) | ||
1 | 65 | 35(53.85) | 30(46.15) | ||
ALT | . | 2.68 | 0.10 | ||
Negative | 97 | 52(53.61) | 45(46.39) | ||
Positive | 22 | 16(72.73) | 6(27.27) | ||
AST | . | 0.00 | 0.95 | ||
Negative | 93 | 53(56.99) | 40(43.01) | ||
Positive | 26 | 15(57.69) | 11(42.31) | ||
PLT | . | 0.33 | 0.57 | ||
Negative | 105 | 61(58.10) | 44(41.90) | ||
Positive | 14 | 7(50.00) | 7(50.00) | ||
TBIL | . | 0.94 | 0.33 | ||
Negative | 98 | 58(59.18) | 40(40.82) | ||
Positive | 21 | 10(47.62) | 11(52.38) | ||
r-GT | . | 0.01 | 0.92 | ||
Negative | 60 | 34(56.67) | 26(43.33) | ||
Positive | 59 | 34(57.63) | 25(42.37) | ||
Lymphatic metastasis | . | 0.76 | 0.38 | ||
Negative | 91 | 54(59.34) | 37(40.66) | ||
Positive | 28 | 14(50.00) | 14(50.00) | ||
Maximum diameter | . | 0.10 | 0.75 | ||
≤ 5 cm | 61 | 34(55.74) | 27(44.26) | ||
>5 cm | 58 | 34(58.62) | 24(41.38) | ||
capsular | . | 0.00 | 0.96 | ||
0 | 68 | 39(57.35) | 29(42.65) | ||
1 | 51 | 29(56.86) | 22(43.14) | ||
Venous tumor thrombus | . | 1.49 | 0.22 | ||
0 | 84 | 51(60.71) | 33(39.29) | ||
1 | 35 | 17(48.57) | 18(51.43) | ||
Density | . | 0.38 | 0.54 | ||
Uniform | 41 | 25(60.98) | 16(39.02) | ||
Uneven | 78 | 43(55.13) | 35(44.87) | ||
Shape | . | 8.26 | 0.04 | ||
round | 15 | 8(53.33) | 7(46.67) | ||
oval | 18 | 12(66.67) | 6(33.33) | ||
lobulate | 39 | 28(71.79) | 11(28.21) | ||
Irregular | 47 | 20(42.55) | 27(57.45) | ||
Margin | . | 0.22 | 0.64 | ||
smooth | 16 | 10(62.50) | 6(37.50) | ||
Non-smooth | 103 | 58(56.31) | 45(43.69) | ||
Lipids | . | 2.71 | 0.10 | ||
0 | 117 | 68(58.12) | 49(41.88) | ||
1 | 2 | 0(0.00) | 2(100.00) | ||
Hepatic atrophy | . | 0.01 | 0.94 | ||
0 | 103 | 59(57.28) | 44(42.72) | ||
1 | 16 | 9(56.25) | 7(43.75) | ||
Hepatic capsular retraction | . | 0.29 | 0.59 | ||
0 | 88 | 49(55.68) | 39(44.32) | ||
1 | 31 | 19(61.29) | 12(38.71) | ||
Intrahepatic duct dilatation | . | 0.15 | 0.70 | ||
0 | 93 | 54(58.06) | 39(41.94) | ||
1 | 26 | 14(53.85) | 12(46.15) | ||
schedule of reinforcement | . | 0.12 | 0.94 | ||
Ring strengthening | 40 | 22(55.00) | 18(45.00) | ||
Uniform | 74 | 43(58.11) | 31(41.89) | ||
Uneven | 5 | 3(60.00) | 2(40.00) | ||
TIC curve | . | 1.03 | 0.31 | ||
centripetal reinforcement | 67 | 41(61.19) | 26(38.81) | ||
Wash in-wash out | 52 | 27(51.92) | 25(48.08) | ||
Peritumoral enhancement | . | 5.95 | 0.01 | ||
0 | 35 | 26(74.29) | 9(25.71) | ||
1 | 84 | 42(50.00) | 42(50.00) | ||